My Story and Me
Cross-source consensus on My Story and Me from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Benefits
Highlighted claims
- My Story and Me is a free, voluntary digital storytelling intervention for girls and young women aged 14–18. — Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
- The intervention aims to reduce stigma, improve mental health literacy, and promote early help-seeking. — Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
- The intervention is designed to include minoritised ethnic, LGBTQIA+, and neurodivergent individuals. — Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
- Participants may watch existing peer stories and optionally record their own stories. — Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
- The intervention is theoretically based on mentalisation through exposure to stories from others with shared identities. — Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial